Contrast-Enhanced Spectral Mammography and tumor size assessment: a valuable tool for appropriate surgical management of breast lesions

• DOI: 10.1007/s11547-022-01561-x
• Publication Date: 2022-09-23T14:02:45Z
• Authors: Luca Nicosia; Anna Carla Bozzini; Simone Palma; Marta Montesano; Giulia Signorelli; Filippo Pesapane; Antuono Latronico; Vincenzo Bagnardi; Samuele Frassoni; Claudia Sangalli; Mariagiorgia Farina; Enrico Cassano
• Keywords: Gold standard (test); Breast tumor; Histology; Breast MRI

To compare the accuracy of Contrast-Enhanced Spectral Mammography (CESM), MG, US, and breast MRI in estimating the size of breast lesions requiring surgery. The postoperative histology size of the lesion was used as the gold standard.Two hundred thirty-three non-benign lesions in 189 patients were included in the analyses. All the selected patients underwent CESM and at least one other conventional diagnostic exam (US, MG, or MRI). Subsequently, all the patients underwent surgery preceded by cytological/histological examination. The largest diameter of the lesion at imaging was measured by a radiologist with more than 10 years' experience and then compared with the size of the lesion in the histological sample at the surgery (gold standard).Among the 233 breast lesions, 196 were evaluated with US, 206 with MG and 160 with MRI. We found no statistically significant differences between size measurements using CESM and MRI compared with the measurements at the surgery (p value 0.63 and 0.51), whereas a significant difference was found for MG and US (p < 0.001).CESM is a reliable method for estimating the size of breast lesions: its performance seems superior to US and MG and comparable to MRI.